CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 14 of 48

Rheumatology (Oxford)

Briefs 521–560 of 1,905 CurrentRheuma has covered from this journal, newest publication first

Latest from Rheumatology (Oxford)

All coverage, newest first

  1. Rheumatology (Oxford)

    Multimodal ultrasound in the assessment of muscle involvement in systemic sclerosis patients: results from a bicentric study

    Cross-sectional studySystemic sclerosis

  2. Rheumatology (Oxford)

    Non-negligible risk of HBV reactivation among rheumatoid arthritis patients receiving JAK inhibitors: bridging the evidence gap

    Cohort studyRA

  3. Rheumatology (Oxford)

    Risk of ischaemic and non-ischaemic heart failure in patients with systemic sclerosis: a population-based study

    Cohort studySystemic sclerosis

  4. Rheumatology (Oxford)

    Treatment and prognostic factors in PMR: a systematic literature review informing German, Austrian and Swiss guidelines

    Cohort studyVasculitis & PMR

  5. Rheumatology (Oxford)

    Targeting axial and peripheral psoriatic arthritis: a retrospective observational study on the clinical relevance of upadacitinib

    Cohort studySpondyloarthritis & PsA

  6. Rheumatology (Oxford)

    The incidence and mortality of connective tissue diseases: a population-level cohort study in England from 2012 to 2023

    Cohort studyAcross diseases

  7. Rheumatology (Oxford)

    Three-year follow up of canakinumab dose extension in children with colchicine resistant fasmilial Mediterranean fever: PeRA-RG Experience

    Cohort studyAutoinflammatory & rare

  8. Rheumatology (Oxford)

    Sensorineural hearing loss in anti-interleukin-1 treated CAPS patients: risk factors and real-life barriers—an observational study

    Cohort studyAutoinflammatory & rare

  9. Rheumatology (Oxford)

    Emphysema elevates the DETECT scores: impact on pulmonary hypertension screening and diagnosis in systemic sclerosis

    Cohort studySystemic sclerosis

  10. Rheumatology (Oxford)

    Biological therapies in paediatric Behçet’s disease: results of an international collaborative study by the PRES Vasculitis Working Party

    Cohort studyPediatric

  11. Rheumatology (Oxford)

    Unveiling the clinical spectrum of ACA-positive SSC-ILD: not as benign as expected

    Cross-sectional studySystemic sclerosis

  12. Rheumatology (Oxford)

    Anti-RNA polymerase III antibodies in systemic sclerosis: prevalence and clinical associations from a systematic review and meta-analysis

    Meta-analysisSystemic sclerosis

  13. Rheumatology (Oxford)

    Individualizing NSAID therapy in axial spondyloarthritis: N-of-1 trials with Bayesian analysis

    Randomized controlled trialSpondyloarthritis & PsA

  14. Rheumatology (Oxford)

    Exploring total inflammatory vascular volume as a diagnostic and prognostic biomarker in giant cell arteritis

    Cohort studyVasculitis & PMR

  15. Rheumatology (Oxford)

    Exposure during pregnancy to Il-1 targeted therapies and pregnancy, foetal and neonatal outcomes: a study from the French Teratology Information Service

    Cohort studyAutoinflammatory & rare

  16. Rheumatology (Oxford)

    Stratification of systemic lupus erythematosus with IGHV4-34 in unswitched memory B cells

    Cross-sectional studyLupus & APS

  17. Rheumatology (Oxford)

    Changes to physical function and body composition during the first 2 years of polymyalgia rheumatica

    Cohort studyVasculitis & PMR

  18. Rheumatology (Oxford)

    Validation and clinical application of 2022 ACR/EULAR criteria for Takayasu arteritis in a large Chinese cohort

    Diagnostic or prognostic studyVasculitis & PMR

  19. Rheumatology (Oxford)

    Factors associated with delay in the diagnosis and treatment of systemic lupus erythematosus in adult patients: a systematic review

    Meta-analysisLupus & APS

  20. Rheumatology (Oxford)

    Thermographic abnormalities associate with electrocardiogram/echocardiographic changes and mortality in systemic sclerosis: a retrospective cohort study

    Cohort studySystemic sclerosis

  21. Rheumatology (Oxford)

    Does symptom duration impact on treatment response in axial spondyloarthritis? A meta-analysis of randomized controlled trials

    Meta-analysisSpondyloarthritis & PsA

  22. Rheumatology (Oxford)

    Risk of total and cause-specific mortality in patients with rheumatoid arthritis-associated interstitial lung disease or bronchiectasis

    Cohort studyRA

  23. Rheumatology (Oxford)

    Anti-cytolethal distending toxin antibodies in systemic sclerosis: associations with gastrointestinal disease and immune dysregulation

    Cross-sectional studySystemic sclerosis

  24. Rheumatology (Oxford)

    Beyond pregnancy in systemic autoimmune diseases: a focus on postpartum experience from a referral centre

    Cohort studyVasculitis & PMR

  25. Rheumatology (Oxford)

    Type I interferon limits interleukin-6 signalling in SLE through shedding interleukin-6 receptors

    Mechanistic studyLupus & APS

  26. Rheumatology (Oxford)

    Shared molecular profiles of anti-PL12 autoantibodies in anti-synthetase syndrome

    Mechanistic studyMyositis

  27. Rheumatology (Oxford)

    Frequency, diagnosis, and management of polymyalgia rheumatica in Germany—database analysis of medical insurance data

    Cross-sectional studyVasculitis & PMR

  28. Rheumatology (Oxford)

    Validation of the Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) in Brazilian SLE patients

    Cross-sectional studyLupus & APS

  29. Rheumatology (Oxford)

    The role of ITIH4 in regulating the PI3K/Akt signalling in rheumatoid arthritis

    Mechanistic studyRA

  30. Rheumatology (Oxford)

    TNF-alpha inhibitors reduce the incidence of PsA in patients with psoriasis: a propensity score-matched cohort study

    Cohort studySpondyloarthritis & PsA

  31. Rheumatology (Oxford)

    Prognostic value of baseline nailfold videocapillaroscopy in predicting pulmonary decline and disease progression in SSc

    Cohort studySystemic sclerosis

  32. Rheumatology (Oxford)

    The therapeutic potential for JAK inhibitors for immune-related adverse events from checkpoint inhibitors: a review of the literature

    Meta-analysis

  33. Rheumatology (Oxford)

    Association of IgG4-related disease with human inborn errors of immunity

    Case-control studyAutoinflammatory & rare

  34. Rheumatology (Oxford)

    High prevalence of MASLD in psoriasis and psoriatic arthritis assessed with multiparametric magnetic resonance imaging

    Cohort studySpondyloarthritis & PsA

  35. Rheumatology (Oxford)

    Sex differences in serum proteomic profiles in psoriatic arthritis

    Cross-sectional studySpondyloarthritis & PsA

  36. Rheumatology (Oxford)

    Neither ultrasound synovitis nor clinical-ultrasound phenotypes of established rheumatoid arthritis predict response to targeted therapy

    Cohort studyRA

  37. Rheumatology (Oxford)

    Higher comorbidities associated with less improvement in disease activity in early RA: results from CATCH cohort

    Cohort studyRA

  38. Rheumatology (Oxford)

    SLE-DAS remission and low disease activity were similarly associated with patient-reported outcomes compared with definition of remission in SLE remission and lupus low disease activity state

    Cross-sectional studyLupus & APS

  39. Rheumatology (Oxford)

    Mapping MSU crystal deposition within MTP joints in tophaceous gout: a dual-energy CT study

    Cross-sectional studyGout & crystals

  40. Rheumatology (Oxford)

    Potential protective role of high Mediterranean diet adherence for systemic lupus erythematosus: mediation by liver and kidney function biomarkers in the UK Biobank cohort

    Cohort studyLupus & APS

All 1,905 Briefs in ExploreShowing Briefs 521–560 of 1,905, newest first